Description: This book focuses on the role of the serotonin system in the etiology of psychotic disorders and their treatment. It also extensively reviews the newer antipsychotic medication risperidol.
Purpose: The purpose is to describe the newer theories of psychosis, specifically focusing on the involvement the serotonin system. It also looks at newer medications developed based on these concepts.
Audience: This book is written for those interested in the neurobiology and neurophysiology of the serotonin system as it relates to psychosis. It also is geared to those interested in the clinical use of newer antipsychotic agents.
Features: The book has an appropriate number of illustrations, tables, and charts. It is well referenced, and the editors and authors are experts in their areas.
Assessment: This is a highly specialized and technical publication focusing on the serotonin system , its role in schizophrenia, and its role in the development of newer antipsychotic medications. It reviews a wide range of topics including the established dopamine theory of psychosis, serotonin's interactions with the dopamine system, its role in antipsychotic treatment and side effects, serotonin receptor subtypes, and its role in the presentation of negative symptoms of schizophrenia. Approximately one quarter of the book is devoted to the review of risperidol, a newer antipsychotic agent, whereas other such agents are briefly mentioned. Overall, it is a compendium of a wide variety of information on the serotonin system and its relationship to schizophrenia.